CD19 and B-cell chronic lymphocytic leukemia: Early clinical studies in adults with chronic lymphocytic leukemia have shown that CAR NK cells are safe and effective, though proof of efficacy outside of targeting CD19 has been inconsistent between in vivo studies and clinical trials [147].